Cosira-II
Research payments
$266,448
Through program year 2023, $266,448 in research payments was reported against Cosira-II, across 35 payments, paid by Neovasc Medical Inc.
- Paid by
- Neovasc Medical Inc
- ClinicalTrials.gov
- No trial number was reported for this study
By program year
3 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2023 | Research | $64,827 | 10 |
| 2022 | Research | $191,246 | 24 |
| 2020 | Research | $10,375 | 1 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
9 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Timothy Henry Cincinnati, OH Named on 9 payments
- Samin Sharma New York, NY Named on 6 payments
- Jaikirshan Khatri Cleveland, OH Named on 2 payments
- David Rizik Scottsdale, AZ Named on 2 payments
- Matheen Khuddus Gainesville, FL Named on 2 payments
- Gerald Koenig Detroit, MI Named on 2 payments
- Kevin Croce Brookline, MA Named on 2 payments
- Michel Corban Tucson, AZ Named on 1 payment
- F Fortuin Phoenix, AZ Named on 1 payment
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.